228 related articles for article (PubMed ID: 20452919)
1. Radiopharmaceutical considerations for using Tc-99m MAA in lung transplant patients.
Ponto JA
J Am Pharm Assoc (2003); 2010; 50(3):419-23. PubMed ID: 20452919
[TBL] [Abstract][Full Text] [Related]
2. Does Heparin Affect
Scotognella T; Lanni V; Moresi F; Rizzo A; Guarneri A; Valenza V
Curr Radiopharm; 2022; 15(3):199-204. PubMed ID: 35125090
[TBL] [Abstract][Full Text] [Related]
3. [Impact of Residual Radioactivity Rate of
Nakamura Y; Kangai Y; Sato S; Shibata S; Abe T; Mimura H; Inubushi M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Aug; 79(8):802-809. PubMed ID: 37357400
[TBL] [Abstract][Full Text] [Related]
4. Changes in Patterns of
Ponto JA
J Nucl Med Technol; 2017 Jun; 45(2):111-113. PubMed ID: 28408704
[TBL] [Abstract][Full Text] [Related]
5. Tailoring 99mTc-Macroaggregated Albumin Administration to Optimize Patient Dose Reduction.
Gales SL; Peters SK; Salehi N; Better N
J Nucl Med Technol; 2015 Sep; 43(3):220-1. PubMed ID: 26271803
[TBL] [Abstract][Full Text] [Related]
6. Breast-milk radioactivity after a Tc-99m DTPA aerosol/Tc-99m MAA lung study.
Mountford PJ; Hall FM; Wells CP; Coakley AJ
J Nucl Med; 1984 Oct; 25(10):1108-10. PubMed ID: 6384439
[TBL] [Abstract][Full Text] [Related]
7. Issues with the European Pharmacopoeia Quality Control Method for
Jensen SB; Meyer LS; Nielsen NS; Nielsen SS
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807243
[TBL] [Abstract][Full Text] [Related]
8. Preclinical characterization of 18F-MAA, a novel PET surrogate of 99mTc-MAA.
Wu SY; Kuo JW; Chang TK; Liu RS; Lee RC; Wang SJ; Lin WJ; Wang HE
Nucl Med Biol; 2012 Oct; 39(7):1026-33. PubMed ID: 22762865
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging.
Hunt AP; Frier M; Johnson RA; Berezenko S; Perkins AC
Eur J Pharm Biopharm; 2006 Jan; 62(1):26-31. PubMed ID: 16154332
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 99mTc(CO)5I as a potential lung perfusion agent.
Miroslavov AE; Gorshkov NI; Lumpov AL; Yalfimov AN; Suglobov DN; Ellis BL; Braddock R; Smith AM; Prescott MC; Lawson RS; Sharma HL
Nucl Med Biol; 2009 Jan; 36(1):73-9. PubMed ID: 19181271
[TBL] [Abstract][Full Text] [Related]
11. Comparison of estimated human dose of (68)Ga-MAA with (99m)Tc-MAA based on rat data.
Shanehsazzadeh S; Lahooti A; Yousefnia H; Geramifar P; Jalilian AR
Ann Nucl Med; 2015 Oct; 29(8):745-53. PubMed ID: 26139003
[TBL] [Abstract][Full Text] [Related]
12. Supine versus prone injection of Tc-99m MAA: evidence of thoracic compression or fluid shift.
Slavin JD; Solis V; Spencer RP
Clin Nucl Med; 2003 Sep; 28(9):764-5. PubMed ID: 12973002
[TBL] [Abstract][Full Text] [Related]
13. Outpatient single-session yttrium-90 glass microsphere radioembolization.
Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
[TBL] [Abstract][Full Text] [Related]
14. The presence of sodium nitrate in generator eluate decreases the radiochemical purity of 99mTc-sestamibi.
Métayé T; Rosenberg T; Guilhot J; Bouin-Pineau MH; Perdrisot R
J Nucl Med Technol; 2012 Sep; 40(3):187-93. PubMed ID: 22872664
[TBL] [Abstract][Full Text] [Related]
15. Krypton-81m ventilation and technetium-99m macroaggregated albumin perfusion scintigraphy for detection of pulmonary embolism: the first experience in Taiwan.
Cherng SC; Yang SP; Wang YF; Jen TK; Huang WS; Lo AR
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Dec; 63(12):876-84. PubMed ID: 11195138
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of normality and reproducibility parameters of scintigraphy with (99m)Tc-MAA in the diagnosis of intrapulmonary vascular dilatations.
de Queirós AS; Brandão SC; Macedo LG; Ourem MS; Mota VG; Leite LA; Lopes EP; Domingues AL
Ann Nucl Med; 2015 Jan; 29(1):46-51. PubMed ID: 25326249
[TBL] [Abstract][Full Text] [Related]
17. Coregistered ventilation and perfusion SPECT using krypton-81m and Tc-99m-labeled macroaggregated albumin with multislice CT utility for prediction of postoperative lung function in non-small cell lung cancer patients.
Ohno Y; Koyama H; Takenaka D; Nogami M; Kotani Y; Nishimura Y; Yoshimura M; Yoshikawa T; Sugimura K
Acad Radiol; 2007 Jul; 14(7):830-8. PubMed ID: 17574133
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three radiochemical purity control methods of (99m)Tc-macroaggregated albumin.
Hallouard F; Paul A; Fraysse M
Curr Radiopharm; 2011 Apr; 4(2):161-6. PubMed ID: 22191656
[TBL] [Abstract][Full Text] [Related]
19. Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography.
Hayashida K; Fukuchi K; Inubushi M; Fukushima K; Imakita S; Kimura K
J Nucl Med; 2001 Jun; 42(6):859-63. PubMed ID: 11390548
[TBL] [Abstract][Full Text] [Related]
20. Prediction of myocutaneous adverse side effect due to intra-arterial chemotherapy by intra-arterial (99m)Tc-macroaggregated albumin administration in patients with bone and soft-tissue tumors.
Taki J; Sumiya H; Higuchi T; Tsuchiya H; Takazawa K; Tomita K; Tonami N
J Nucl Med; 2002 Nov; 43(11):1452-6. PubMed ID: 12411547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
